5447422026-08-195447422026-08-192026-08-19

RelatedPartyTransactionDomain1

5447422026-08-192026-08-19

RelatedPartyTransactionDomain2

5447422026-08-192026-08-19

ResolutionOrAgendaDomain1

5447422026-08-19

ResolutionOrAgendaDomain1

5447422026-08-192026-08-19

ResolutionOrAgendaDomain2

5447422026-08-19

ResolutionOrAgendaDomain2

5447422026-08-192026-08-19

ResolutionOrAgendaDomain3

5447422026-08-19

ResolutionOrAgendaDomain3

5447422026-08-192026-08-19

ResolutionOrAgendaDomain4

5447422026-08-19

ResolutionOrAgendaDomain4

5447422026-08-192026-08-19

ResolutionOrAgendaDomain5

5447422026-08-19

ResolutionOrAgendaDomain5

5447422026-08-192026-08-19

ResolutionOrAgendaDomain6

5447422026-08-19

ResolutionOrAgendaDomain6

5447422026-08-192026-08-19

ResolutionOrAgendaDomain7

5447422026-08-19

ResolutionOrAgendaDomain7

5447422026-08-192026-08-19

ResolutionOrAgendaDomain8

5447422026-08-19

ResolutionOrAgendaDomain8

5447422026-08-192026-08-19

ResolutionOrAgendaDomain9

5447422026-08-19

ResolutionOrAgendaDomain9

5447422026-08-192026-08-19

ResolutionOrAgendaDomain10

5447422026-08-19

ResolutionOrAgendaDomain10

5447422026-08-192026-08-19

ResolutionOrAgendaDomain11

5447422026-08-19

ResolutionOrAgendaDomain11

5447422026-08-192026-08-19

ResolutionOrAgendaDomain12

5447422026-08-19

ResolutionOrAgendaDomain12

iso4217:INRxbrli:pure

SAI PARENTERALS LIMITED

SAIPARENT

New

2026-08-11

11:00:00

2026-08-19

Annual General Meeting

Video Conference (VC) or Other Audio-Visual Means (OAVM)

Thursday

2026-09-10

11:00:00

Through Video Conference or Other Audio Visual Means

Sai Parenterals Limited

NOUMED PHARMACEUTICALS PTY. LIMITED

Step Down Subsidiary

Loan

120750000

2026-04-01

2027-03-31

Sai Parenterals Limited

NOUMED PHARMACEUTICALS PTY. LIMITED

Step Down Subsidiary

Sale of goods or services

480000000

2026-04-01

2027-03-31

Ordinary Resolution

Adoption of Financial Statements

To receive, consider and adopt the Audited Balance Sheet as at March 31st, 2026, the Statement of Profit & Loss and Cash Flow Statement, (Standalone and consolidated) for the year ended on that date together with the Notes attached thereto, along with the Reports of Auditors and Directors thereon.

Ordinary Resolution

Others

Retirement of Rotation

To appoint a director in place of Mr. Anil Kumar Karusala (DIN: 01866646) who retires by rotation and being eligible, offers himself for re-appointment.

Special Resolution

Appointment/Re-appointment/Removal/Ratification/Retirement/Remuneration

Re-appointment

RE-APPOINTMENT OF MR. ANIL KUMAR KARUSALA AS MANAGING DIRECTOR.

Executive Director

Anil Kumar Karusala

01866646

2027-01-01

2029-12-31

Special Resolution

Appointment/Re-appointment/Removal/Ratification/Retirement/Remuneration

Re-appointment

RE-APPOINTMENT OF MRS. VIJITHA GORREPATI AS WHOLE-TIME DIRECTOR

Executive Director

Vijitha Gorrepati

03492979

2027-01-01

2029-12-31

Special Resolution

Appointment/Re-appointment/Removal/Ratification/Retirement/Remuneration

Appointment

TO APPOINT MR. KUNAL KAKUMANU (DIN:11281388) AS AN EXECUTIVE DIRECTOR OF THE COMPANY

Executive Director

Kunal Kakumanu

11281388

2026-08-11

2029-08-10

Ordinary Resolution

Others

Appointment of Secretarial Auditors

TO APPOINT M/S. AAKANKSHA DUBEY & CO., PRACTICING COMPANY SECRETARIES AS SECRETARIAL AUDITORS FOR A TERM OF UPTO 5 (FIVE) CONSECUTIVE YEARS.

Special Resolution

Others

Variation in IPO Objects

VARIATION IN THE OBJECTS AND/OR TERMS OF UTILISATION OF THE IPO PROCEEDS AND EXTENSION OF THE TIME PERIOD FOR UTILISATION OF THE IPO PROCEEDS AS DISCLOSED IN THE PROSPECTUS DATED MARCH 28, 2026, RELATING TO OBJECTS (A) CAPACITY EXPANSION AND UPGRADATION OF MANUFACTURING FACILITIES AND (B) ESTABLISHMENT OF A RESEARCH & DEVELOPMENT CENTRE

Special Resolution

Others

Ratification of ESOP Scheme

RATIFICATION OF THE SAI PARENTERAL’S LIMITED EMPLOYEE STOCK OPTION PLAN 2025 (“ESOP SCHEME - 2025”) OF THECOMPANY:

Special Resolution

Others

Ratification of Extension of ESOP Scheme

RATIFICATION OF THE EXTENSION OF BENEFITS OF THE SAI PARENTERAL’S LIMITED EMPLOYEE STOCK OPTION PLAN 2025 (“ESOP SCHEME - 2025”) TO THE SUBSIDIARY COMPANIES.

Ordinary Resolution

Related Party Transaction

TO CONSIDER AND APPROVE THE MATERIAL RELATED PARTY TRANSACTION OF THE COMPANY IN RESPECT OF THE GRANT OF A LOAN TO SAI SINGAPORE PTE. LTD. FOR DOWNSTREAM FUNDING TO NOUMED PHARMACEUTICALS PTY. LIMITED, AUSTRALIA.

Ordinary Resolution

Related Party Transaction

TO APPROVE MATERIAL RELATED PARTY TRANSACTIONS OF THE COMPANY WITH NOUMED PHARMACEUTICALS PTY. LIMITED, STEP-DOWN SUBSIDIARY COMPANY FOR THE FY 2026-27.

Ordinary Resolution

Others

Ratification of Remuneration of Cost Auditor

RATIFICATION OF PAYMENT OF REMUNERATION TO THE COST AUDITOR FOR THE FINANCIALYEAR 2026-27